Russell Investments Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Russell Investments Group’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,084	Closed	-$63K	–	3074
2018 Q2	$63K	Buy	+7,084	New	+$63.7K	﹤0.01%	2790
2017 Q1	–	Sell	-200	Closed	-$1K	–	3157
2016 Q4	$1K	Buy	+200	New	+$1.1K	﹤0.01%	3066

Russell Investments Group's JNP Position: Q3 2018 in Review

Russell Investments Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 7,084 shares — an estimated $63K sold.

Russell Investments Group first reported a position in JNP in Q4 2016 and held it in 2 quarters. The position peaked at $63K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Russell Investments Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Russell Investments Group sold 7,084 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $63K.
Russell Investments Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
Russell Investments Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $63K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Russell Investments Group's 13F filing for Q3 2018, filed 26 Oct 2018.